Immunic
Develops oral small-molecule candidates for multiple sclerosis and other inflammatory or autoimmune diseases.
$15.40
After-hours close+0.02 (+0.10%)
At close$15.39(−5.61%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 61.95%8.44M sharesInsiders 3.48%473.9K sharesOther 34.57%4.71M shares
Shares outstanding 13.62M · Float 11.84M · 86.9% free float
A split settled inside the quarter being compared, so quarter-on-quarter change is not shown.
Institutions13F, as of Jun 30, 2026
60 holders · 8.44M shares
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Abrdn PLC | 824.4K | 6.05% | Jul 31, 2026 | |
| BVF Inc/IL | 765.3K | 5.62% | Aug 14, 2026 | |
| Millennium Management LLC | 740.3K | 5.44% | Aug 14, 2026 | |
| Avidity Partners Management LP | 669.9K | 4.92% | Aug 14, 2026 | |
| Braidwell LP | 645.0K | 4.74% | Aug 14, 2026 | |
| Laurion Capital Management LP | 610.3K | 4.48% | Aug 13, 2026 | |
| Vanguard Capital Management LLC | 571.6K | 4.20% | Aug 13, 2026 | |
| Jones Hill Capital LP | 539.8K | 3.96% | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 9.99% | 13G | Feb 20, 2026 ↗ | |
| Janus Henderson Group PLC | 9.99% | 13G | Dec 8, 2025 ↗ | |
| Adage Capital Management, L.P. | 9.99% | 13G | Aug 12, 2025 ↗ | |
| Avidity Partners Management LP | 9.90% | 13G | Apr 17, 2026 ↗ | |
| Commodore Capital LP | 9.90% | 13G | Feb 24, 2026 ↗ | |
| Trails Edge Capital Partners, LP | 8.70% | 13G | Feb 24, 2026 ↗ | |
| Deep Track Capital, LP | 8.69% | 13G | Mar 4, 2026 ↗ | |
| Nantahala Capital Management, LLC | 8.22% | 13G | Feb 13, 2026 ↗ | |
| Biotechnology Value Fund L P | 7.40% | 13D | Feb 20, 2026 ↗ | |
| Aberdeen Group plc | 6.85% | 13G | Feb 2, 2026 ↗ | |
| Laurion Capital Management LP | 6.06% | 839.5K | 13G | Aug 4, 2026 ↗ |
| 683 Capital Management, LLC | 5.90% | 13G | Feb 17, 2026 ↗ | |
| Soleus Capital Master Fund, L.P. | 5.50% | 13G | Feb 19, 2026 ↗ | |
| Integrated Core Strategies (US) LLC | 5.40% | 743.3K | 13G | May 6, 2026 ↗ |
| OrbiMed Advisors LLC | 5.30% | 756.9K | 13G | Aug 14, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| BVF Partners L P/IL | director, other: See Explanation of Responses | 413.6K | 3.04% | Feb 27, 2026 |
| Richard Alan Rudick | director | 23.0K | 0.17% | Jun 4, 2025 |
| Joerg Neermann | director | 20.0K | 0.15% | Jun 5, 2025 |
| Glenn Whaley | officer: Chief Financial Officer | 9.6K | 0.07% | Jun 4, 2025 |
| Duane Nash | director, officer: Executive Chairman | 3.6K | 0.03% | Jun 16, 2025 |
| Daniel Vitt | director, officer: CEO and Director | 2.9K | 0.02% | Jun 6, 2025 |
| Jason Tardio | officer: President and COO | 1.3K | 0.01% | Jun 9, 2025 |
3 ten-percent owners hold 490.6K shares by Form 4, outside the officers-and-directors figure above · 13 people have not refiled in the last 18 months (195.6K shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.